POSTMENOPAUSAL OSTEOPOROSIS
Clinical trials for POSTMENOPAUSAL OSTEOPOROSIS explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL OSTEOPOROSIS trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New osteoporosis drug shows promise in Head-to-Head trial
Disease control CompletedThis study compared a new drug called Enzene denosumab (ENZ215) to the approved drug Prolia in 504 postmenopausal women with osteoporosis. The goal was to see if the new drug works as well at improving bone density and controlling bone breakdown over 12 months. The trial is compl…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE3 • Sponsor: Enzene Biosciences Ltd. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New osteoporosis drug safety checked in indian women
Disease control CompletedThis study tested the safety of a drug called romosozumab (EVENITY) in 100 postmenopausal women in India who have osteoporosis and a high risk of breaking a bone. The main goal was to see what side effects occurred. The drug is already approved and aims to strengthen bones, but t…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated May 11, 2026 20:50 UTC